The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Clinical Epidemiology of Cardiac Disease in Dialysis Patients: Left Ventricular Hypertrophy, Ischemic Heart Disease, and Cardiac Failure
Abstract
Patients with end‐stage renal disease (ESRD) are at extreme cardiovascular risk. At least half of all patients starting dialysis therapy have overt cardiovascular disease (CVD). In addition, recent studies suggest annual incidence rates for new‐onset cardiac failure, peripheral vascular disease, ischemic heart disease (IHD), and stroke of approximately 7%, 7%, 5%, and 1%, respectively. High‐level exposure to traditional risk factors, such as smoking and dyslipidemia, hemodynamic overload factors, such as anemia and hypertension, and a myriad of metabolic factors related to uremia are all likely to play a role. There has been explosive growth in observational studies and a heartening, if less dramatic, increase in risk factor intervention trials, suggesting that risk factor modification can lead to meaningful benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Besarab, A., Bolton, W. K., Browne, J. K., Egrie, J. C., Nissenson, A. R., Okamoto, D. M., Schwab, S. J., & Goodkin, D. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390903 · Cited by 1,930
Franklin, S. S., Larson, M. G., Khan, S. A., Wong, N. D., Leip, E. P., Kannel, W. B., & Levy, D. (2001) · Circulation · doi:10.1161/01.cir.103.9.1245 · Cited by 1,390
Levin, A., Singer, J., Thompson, C. R., Ross, H., & Lewis, M. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90357-1 · Cited by 709
Long-term evolution of cardiomyopathy in dialysis patients
Foley, R. N., Parfrey, P. S., Kent, G. M., Harnett, J. D., Murray, D. C., & Barre, P. E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00154.x · Cited by 226
Self-citation
Research works printed but not linked: 67
- FoleyRN HerzogCA CollinsAJ:Smoking and cardiovascular outcomes in dialysis patients. The United States Renal Data System Wave 2 Study.Kidney Int:(in press) 2002
- 10.1038/ki.1995.22 · DOI · Paper page
- 10.1681/ASN.V12122759 · DOI · Paper page
- 10.1681/ASN.V12122768 · DOI · Paper page
- 10.1001/jama.268.12.1545 · DOI
- 10.1046/j.1523-1755.2002.00362.x · DOI
- 10.1097/00007890-200107150-00021 · doi:10.1097/00007890-200107150-00021
- 10.1097/00007890-199511150-00005 · DOI
- 10.1097/00007890-200008270-00006 · DOI
- 10.1097/00007890-200207150-00013 · DOI
- Foley RN, 2000, Serial change in echocardiographic parameters and cardiac failure in end‐stage renal disease, J Am Soc Nephrol, 11, 912, 10.1681/ASN.V115912 · DOI · Paper page
- 1992, Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients, Am J Kidney Dis, 20, 32
- 10.1038/ki.1995.132 · DOI · Paper page
- Tonelli M, 2001, Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency, Am J Kidney Dis, 37, 484, 10.1053/ajkd.2001.22070 · doi:10.1053/ajkd.2001.22070 · Paper page
- 10.1038/ki.1996.349 · doi:10.1038/ki.1996.349
- 10.1681/ASN.V114753 · DOI · Paper page
- 10.1097/01.ASN.0000018401.82863.FD · DOI · Paper page
- 10.2337/diacare.25.4.742 · DOI · Paper page
- 10.1016/S0002-9149(99)80683-3 · DOI · Paper page
- 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
- Manske CL, 1992, Prevalence of and risk factors for angiographically determined coronary artery disease in type I‐diabetic patients with nephropathy, Arch Intern Med, 152, 2450, 10.1001/archinte.1992.00400240070012 · doi:10.1001/archinte.1992.00400240070012
- 10.1016/S0140-6736(94)92935-1 · DOI · Paper page
- 10.1177/096368970000900617 · DOI
- 10.1016/S0140-6736(98)04433-X · DOI · Paper page
- 10.1056/NEJM199604113341502 · DOI · Paper page
- 10.1056/NEJM198706043162301 · DOI · Paper page
- Cleland JG, 1997, Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators, Eur Heart J, 18, 41, 10.1093/eurheartj/18.1.41 · DOI
- U.S. Renal Data System:, 1992, USRDS 1992 annual report. IV. Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients, Am J Kidney Dis, 32
- 10.1016/S0272-6386(12)70364-5 · DOI · Paper page
- 10.1038/ki.1996.194 · DOI · Paper page
- 10.1053/ajkd.2000.19100 · DOI
- 10.1093/ndt/12.4.724 · DOI
- 10.1016/S0272-6386(99)70187-3 · DOI · Paper page
- 10.1016/S0272-6386(96)90309-1 · doi:10.1016/s0272-6386(96)90309-1
- 10.1093/ndt/14.11.2599 · doi:10.1093/ndt/14.11.2599
- 10.1053/ajkd.2001.26103 · DOI · Paper page
- 10.1161/01.CIR.90.6.2786 · DOI · Paper page
- 10.1016/S0895-7061(00)01232-2 · DOI · Paper page
- 10.1046/j.1523-1755.2002.00173.x · DOI · Paper page
- 10.1001/jama.287.12.1548 · DOI · Paper page
- 10.1046/j.1523-1755.2002.00636.x · DOI · Paper page
- 10.1038/ki.1996.355 · DOI · Paper page
- 10.1161/01.CIR.86.2.475 · DOI · Paper page
- 10.1016/S0272-6386(12)70189-0 · doi:10.1016/s0272-6386(12)70189-0
- 10.1046/j.1523-1755.1999.07158.x · DOI
- Baigent C, 2001, Efficacy and safety of simvastatin and low‐dose aspirin among patients with chronic renal disease: the UK‐Heart and Renal Protection (UK‐HARP) pilot study [abstract], J Am Soc Nephrol, 12, 190A
- Tonelli M, 2001, Pravastatin is effective for secondary prevention of cardiovascular events in patients with chronic renal insufficiency [abstract], J Am Soc Nephrol, 12, 252A
- 10.1016/0272-6386(95)90645-2 · DOI
- 10.1016/S0272-6386(99)70118-6 · DOI · Paper page
- 10.1016/S0272-6386(96)90130-4 · DOI · Paper page
- 10.1681/ASN.V8121921 · DOI · Paper page
- 10.1681/ASN.V103610 · DOI · Paper page
- 10.7326/0003-4819-121-5-199409010-00009 · DOI · Paper page
- 10.1056/NEJM199910213411706 · DOI · Paper page
- 10.1046/j.1523-1755.2000.00289.x · DOI · Paper page
- 10.1093/ndt/14.5.1182 · doi:10.1093/ndt/14.5.1182
- 10.1093/ndt/15.9.1425 · DOI
- Middleton RJ, 2001, Left ventricular hypertrophy in the renal patient, J Am Soc Nephrol, 12, 1079, 10.1681/ASN.V1251079 · DOI · Paper page
- 10.1038/ki.1987.94 · DOI · Paper page
- 10.1053/ajkd.1998.v31.pm9531176 · DOI · Paper page
- 10.1093/ndt/15.7.1014 · DOI · Paper page
- 10.1046/j.1523-1755.2002.00434.x · DOI · Paper page
- 10.1016/S0272-6386(00)70200-9 · DOI · Paper page
- Foley RN, 1996, Hypoalbuminemia, cardiac morbidity, and mortality in end‐stage renal disease, J Am Soc Nephrol, 7, 728, 10.1681/ASN.V75728 · DOI · Paper page
- 10.1681/ASN.V1271549 · DOI · Paper page
- 10.1016/S0140-6736(00)02783-5 · DOI · Paper page
- 10.1681/ASN.V104891 · DOI · Paper page
Cited by
Steinberg, J. S., Varma, N., Cygankiewicz, I., Aziz, P., Balsam, P., Baranchuk, A., Cantillon, D. J., Dilaveris, P., Dubner, S. J., El-Sherif, N., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.038 · Cited by 303
Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics
Pun, P. H., Lehrich, R. W., Honeycutt, E. F., Herzog, C. A., & Middleton, J. P. (2011) · Kidney International · doi:10.1038/ki.2010.315 · Cited by 277
Ayus, J. C., Mizani, M. R., Achinger, S. G., Thadhani, R., Go, A. S., & Lee, S. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040392 · Cited by 265
Metadata
- Authors
- Foley, R. N.
- Venue
- Seminars in Dialysis
- Publisher
- Wiley
- Published
- 2003-03
- Volume
- 16
- Issue
- 2
- Pages
- 111-117
- ISSN
- 0894-0959 (ISSN-L)
- 1525-139X
- OpenAlex
- W2107703251
- Cited by
- 171
- References
- 7
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.